CD19 and neoplasm: In this setting, after an early phase in which CD44v6.CAR T treated tumors seemed to growth as CD19.CAR T treated controls, the tumors were completely controlled by CD44v6.CAR T up to day 20 (Figure 4G), when in one out of four mice, tumor started growing again.